Recent Articles from GlobeNewswire

Itron Prices Upsized $700.0 Million 0.00% Convertible Senior Notes Offering
LIBERTY LAKE, Wash., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Itron, Inc. (NASDAQ: ITRI) (the “Company”), which is innovating new ways for utilities and cities to manage energy and water, today announced the pricing of its private offering of $700.0 million aggregate principal amount of its 0.00% convertible senior notes due 2032 (the “Notes”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering size was increased from the previously announced offering size of $600.0 million aggregate principal amount of Notes. The Company also granted the initial purchasers of the Notes an option to purchase, for settlement during a 13-day period beginning on, and including the first day the Notes are issued, an additional $105.0 million aggregate principal amount of Notes. The offering is expected to settle on February 26, 2026, subject to customary closing conditions.
By Itron, Inc. · Via GlobeNewswire · February 23, 2026
Bankruptcy Plan Filed to Pave Way for Sale of Oceanwide Plaza, Downtown Los Angeles' “Graffiti Towers”
$470 Million Transaction Led by Hilco Global Sets the Stage for Completion of 1.5-Million-Square-Foot Project Ahead of the 2028 Los Angeles Olympic Games
By Hilco Global · Via GlobeNewswire · February 23, 2026
Verisk Analytics, Inc. Prices Offering of Senior Notes
JERSEY CITY, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Verisk Analytics, Inc. (Nasdaq: VRSK) (“Verisk” or the “Company”), a leading strategic data analytics and technology partner to the global insurance industry, today announced the pricing of an offering of $500 million of 4.450% Senior Notes due 2031 (the “2031 Notes”) and $500 million of 5.125% Senior Notes due 2036 (the “2036 Notes” and, together with the 2031 Notes, the “Notes”). The closing of the offering is expected to occur on February 26, 2026, subject to satisfaction of customary closing conditions.
By Verisk Analytics, Inc. · Via GlobeNewswire · February 23, 2026
First Community Credit Union Celebrates Major Milestone with Large Donation to Houston Charities
Houston, TX, Feb. 23, 2026 (GLOBE NEWSWIRE) -- First Community Credit Union (First Community) proudly announced the achievement of a major strategic milestone, reaching $2.9 billion in assets, marking the successful attainment of a long‑term organizational goal. In celebration, First Community is honoring its people‑first mission by announcing a $228,500 donation, funded by its employees, to two impactful Houston nonprofits: Bo’s Place and Houston Children’s Charity. This milestone and the accompanying charitable gift underscore the credit union’s commitment to supporting the communities it serves and recognizing the employees who make its continued growth possible.
By First Community Credit Union · Via GlobeNewswire · February 23, 2026
ALVO INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Alvotech
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its investigation on behalf of Alvotech (“Alvotech” or the “Company”) (NASDAQ:ALVO) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices.
By Kirby McInerney LLP · Via GlobeNewswire · February 23, 2026
Bragar Eagel & Squire, P.C. Reminds Ramaco Resources and Beyond Meat Investors with Large Losses to Contact the Firm Before Upcoming Lead Plaintiff Deadlines
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Ramaco Resources, Inc. (NASDAQ:METC) and Beyond Meat, Inc. (NASDAQ:BYND). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · February 23, 2026
Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Navan, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Navan (NAVN) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · February 23, 2026
CORCEPT CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Corcept Therapeutics Incorporated and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Corcept (CORT) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · February 23, 2026
OSTIN LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Ostin Technology Group Co., Ltd. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Ostin (OST) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · February 23, 2026
Supernus Pharmaceuticals to Participate in March Investor Conferences
ROCKVILLE, Md., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that management will participate in the following March investor conferences:
By Supernus Pharmaceuticals, Inc. · Via GlobeNewswire · February 23, 2026
MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial
FDA has placed partial clinical hold on LINNET study of lorigerlimab in gynecologic cancer
By MacroGenics, Inc. · Via GlobeNewswire · February 23, 2026
GEMI SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Gemini Space Station, Inc. (“Gemini” or the “Company”) (NASDAQ:GEMI) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.
By Kirby McInerney LLP · Via GlobeNewswire · February 23, 2026
DOOR INVESTOR REMINDER: Masonite International Corporation Investors Have Until April 7, 2026 To Seek Lead Plaintiff Role – Kirby McInerney LLP
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- If you sold your Masonite International Corporation (“Masonite” or the “Company”) (NYSE:DOOR) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
By Kirby McInerney LLP · Via GlobeNewswire · February 23, 2026
Ero Announces Inaugural PEA for Furnas, Outlines Low Capital Intensity Project with a 24-Year Initial Mine Life
(all amounts in US dollars and shown on a 100% Project basis, unless otherwise noted)
By Ero Copper Corp. · Via GlobeNewswire · February 23, 2026
AMC Networks Announces Any and All Exchange Offer and Consent Solicitation for its 10.25% Senior Secured Notes due 2029
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- AMC Networks Inc. (the “Company” or “AMC Networks”) (Nasdaq: AMCX) today announced the commencement of an exchange offer (the “Exchange Offer”) to Eligible Holders (as defined below) to exchange any and all of its outstanding 10.25% Senior Secured Notes due 2029 (the “Old Notes”) for its newly-issued 10.50% Senior Secured Notes due 2032 (the “New Notes”), on the terms and subject to the conditions set forth in a Confidential Offering Memorandum and Consent Solicitation Statement, dated as of February 23, 2026 (the “Offering Memorandum”).
By AMC Networks Inc. · Via GlobeNewswire · February 23, 2026
AMC Networks Announces Effectiveness of Amendments to its 10.50% Senior Secured Notes due 2032 and Extension of Consent Solicitation
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- AMC Networks Inc. (“AMC Networks” or the “Company”) (Nasdaq: AMCX) announced today the receipt of Requisite Consents (as defined below) from holders of its existing 10.50% Senior Secured Notes due 2032 (the “Notes”) and the effectiveness of amendments to the indenture governing the Notes to (1) amend the covenant that limits restricted payments in order to permit buybacks, purchases, redemptions, retirements or other acquisitions of AMC Networks Inc.’s equity interests in an aggregate amount not to exceed $50,000,000; (2) revise the covenant that limits transfers or licenses of certain trademarks to unrestricted subsidiaries to only permit transfers of non-exclusive licenses; and (3) restrict investments in unrestricted subsidiaries made pursuant to the definition of “Permitted Investments” to certain specified clauses in such definition (the “Amendments”).
By AMC Networks Inc. · Via GlobeNewswire · February 23, 2026
Palvella Therapeutics to Host Conference Call to Discuss Topline Results from Phase 3 SELVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) in Microcystic Lymphatic Malformations
Webcast conference call to take place tomorrow, Tuesday, February 24, 2026, at 8:00am ET
By Palvella Therapeutics Inc. · Via GlobeNewswire · February 23, 2026
OCI Energy and Arava Power have closed construction financing with ING Capital to support a 347 MWdc solar energy project near Houston
SAN ANTONIO, Feb. 23, 2026 (GLOBE NEWSWIRE) -- OCI Energy LLC (“OCI Energy”), Arava Power, and ING Capital LLC (“ING”) (together, the “Companies”) today announced the successful close of construction financing for Project SunRoper, a 347 MWdc solar project located in Wharton County, Texas. This is the second such transaction between OCI Energy and ING, previously having worked together on financing for the Alamo City Battery Energy Storage System project, and the first among the three Companies.
By OCI Energy · Via GlobeNewswire · February 23, 2026
From Capitol Hill to the Cays: The Bahamas Brings “A Lifetime of Islands” to Washington, D.C.
Nassau, The Bahamas, Feb. 23, 2026 (GLOBE NEWSWIRE) -- The Bahamas Ministry of Tourism, Investments & Aviation brought the vibrant spirit and warmth of the islands to Washington, D.C. on February 19th, hosting a targeted sales and marketing mission designed to strengthen strategic partnerships and drive continued visitation to The Bahamas.
By The Bahamas Ministry of Tourism · Via GlobeNewswire · February 23, 2026
Calian Appoints Will Majic as Acting Chief Financial Officer
OTTAWA, Ontario, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Calian Group Ltd. (TSX: CGY), a mission-critical solutions company focused on defence, space, healthcare and other strategic critical infrastructure sectors, today announced the appointment of Will Majic as acting Chief Financial Officer, effective immediately.
By Calian Group Ltd. · Via GlobeNewswire · February 23, 2026
NJDCY Announcement: If You Have Suffered Losses in Nidec Corporation (OTC: NJDCY), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · February 23, 2026
Smith+Nephew signs distribution agreement with SI-BONE
Trauma and Extremities partnership aligns disciplined approach to portfolio optimization and focuses on delivering long-term value for surgeons and patients 
By Smith & Nephew UK Ltd · Via GlobeNewswire · February 23, 2026
Ultragenyx to Participate at Investor Conferences in March
NOVATO, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced participation in three upcoming investor conferences.
By Ultragenyx Pharmaceutical Inc. · Via GlobeNewswire · February 23, 2026
DHT Holdings, Inc. secures one-year time charter for DHT Redwood
HAMILTON, BERMUDA, February 23, 2026 – DHT Holdings, Inc. (NYSE:DHT) (“DHT” or the “Company”) today announced it has entered into a one-year time charter agreement at $105,000 per day for the VLCC DHT Redwood, built in 2011. The contract is expected to commence in March 2026 and has been concluded with a global energy company.
By DHT Holdings, Inc. · Via GlobeNewswire · February 23, 2026
ONEOK Announces Higher Full-Year 2025 Earnings: Net Income up 11%, Adjusted EBITDA up 18%
ONEOK Announces 2026 Financial Guidance
By ONEOK, Inc. · Via GlobeNewswire · February 23, 2026
FinWise Bancorp Announces Agreement with Albert Corporation to Offer Millions of Americans Transparent, Affordable and Convenient Short-term Personal Loans
MURRAY, Utah, Feb. 23, 2026 (GLOBE NEWSWIRE) -- FinWise Bancorp (NASDAQ: FINW) (“FinWise” or the “Company”), parent company of FinWise Bank (the “Bank”), today announced a strategic program agreement with leading fintech Albert Corporation (“Albert”). Since its launch in 2016, Albert has helped millions of Americans automate their finances, get smarter about their money and improve their financial stability.
By FinWise Bank · Via GlobeNewswire · February 23, 2026
AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference
VALENCIA, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced Cary Vance, Interim CEO, and David O’Toole, CFO, will be participating in the upcoming TD Cowen 46th Annual Health Care Conference in Boston, MA.
By AVITA Medical · Via GlobeNewswire · February 23, 2026
Silo Pharma Announces Share Buyback Program
Sarasota, FL, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that its board of directors has authorized a share repurchase program to acquire up to $1million of the Company's common stock. The Company may purchase common stock on the open market, through privately negotiated transactions, or otherwise, in compliance with the rules of the United States Securities and Exchange Commission and other applicable legal requirements.   The Company had 13,318,273 shares of common stock outstanding as of November 13, 2025, as reported in its Quarterly Report for the period ended September 30, 2025.
By Silo Pharma, Inc. · Via GlobeNewswire · February 23, 2026
European Wax Center, Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 4th
PLANO, Texas, Feb. 23, 2026 (GLOBE NEWSWIRE) -- European Wax Center, Inc. (NASDAQ: EWCZ), a leading franchisor and operator of out-of-home waxing services in the United States, today announced that it plans to report fourth quarter and fiscal year 2025 financial results before the market opens on Wednesday, March 4, 2026.
By European Wax Center, Inc. · Via GlobeNewswire · February 23, 2026
General Fusion to Highlight Commercialization Path and Capital Markets Strategy at Upcoming Global Fusion Industry and Investor Conferences
VANCOUVER, British Columbia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- General Fusion Inc. (“General Fusion” or the “Company”), a leader in the global race to make commercial fusion energy a reality, today announced its participation in several prominent global conferences throughout February and March. Company executives will highlight General Fusion’s commercialization strategy, capital markets path, and the role of fusion in the future clean energy mix. The Company recently announced its plans to go public through a business combination (the transactions contemplated by the business combination, collectively, the “Proposed Business Combination”) with Spring Valley Acquisition Corp. III (NASDAQ: SVAC) (“SVAC”). 
By General Fusion · Via GlobeNewswire · February 23, 2026
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in March
CAMBRIDGE, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, today announced that management will participate in two upcoming fireside chats in March:
By Relay Therapeutics, Inc. · Via GlobeNewswire · February 23, 2026
Great Lakes Reports Fourth Quarter and Full Year 2025 Results and the Signing of Two International Offshore Energy Contracts
Record full year revenue of $888.3 millionFull year net income of $73.5 million (Adjusted net income of $81.6 million)Record full year Adjusted EBITDA of $171.3 million
Phillips Edison & Company to Present at Citi’s 2026 Global Property CEO Conference
CINCINNATI, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or “the Company”), one of the nation’s largest owners and operators of high-quality, grocery-anchored neighborhood shopping centers, today announced that the Company will participate in a roundtable presentation at Citi’s 2026 Global Property CEO Conference on Monday, March 2, 2026 at 8:10 a.m. ET.
By Phillips Edison & Company, Inc. · Via GlobeNewswire · February 23, 2026
ROC Announces Closing of Upsized Initial Public Offering
DENVER, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Rank One Computing Corporation d/b/a ROC, (Nasdaq: ROC) (“ROC” or the “Company”), a U.S. leader in multimodal Vision AI, building sovereign biometric, video analytics, and mission intelligence solutions into a unified platform, today announced the closing of its previously announced Initial Public Offering (the “Offering”) of 4,000,000 shares of common stock at a public offering price of $6.00 per share, which was the high end of the range, for total gross proceeds of $24 million, before deducting underwriting discounts and commissions and other Offering expenses. The Company intends to use the net proceeds from the Offering (i) to hire key resources that enable growth and support market share capture; (ii) to update and expand our neural-processing infrastructure to accelerate the pace in which we train and deploy Vision AI algorithms; and (iii) for working capital and general corporate purposes. In connection with the Offering, ROC has granted the underwriter a 30-day option to purchase up to an additional 600,000 shares of its common stock to cover over-allotments, if any.
By ROC · Via GlobeNewswire · February 23, 2026
Sana Biotechnology to Present at March 2026 Investor Conferences
SEATTLE, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor conferences in March. The presentations will feature a business overview and update.
By Sana Biotechnology, Inc · Via GlobeNewswire · February 23, 2026
MediaAlpha Announces Fourth Quarter and Full Year 2025 Financial Results
Fourth Quarter Revenue of $291 million and Record Transaction Value of $613 million; Record Transaction Value of $552 million in Property & Casualty Insurance Vertical
By MediaAlpha, Inc. · Via GlobeNewswire · February 23, 2026
Olaplex Holdings, Inc. to Report Fourth Quarter and Fiscal 2025 Financial Results on March 5th
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (“OLAPLEX”), today announced that it plans to report fourth quarter and fiscal 2025 financial results before the market opens on Thursday, March 5, 2026.
By Olaplex Holdings, Inc. · Via GlobeNewswire · February 23, 2026
Tarsus Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Achievements
Generated full-year 2025 net product sales of XDEMVY® of $451.4 million, an increase of more than 150% year-over-year
By Tarsus Pharmaceuticals, Inc · Via GlobeNewswire · February 23, 2026
EverQuote Announces Fourth Quarter and Full Year 2025 Financial Results
CAMBRIDGE, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- EverQuote, Inc. (Nasdaq: EVER), a leading online insurance marketplace, today announced financial results for the fourth quarter and full year ended December 31, 2025.
By EverQuote, Inc. · Via GlobeNewswire · February 23, 2026
Adeia Announces Record Fourth Quarter and Full Year 2025 Financial Results
Achieved record revenue, operating income and adjusted EBITDA in the fourth quarter Signed long-term license agreement with Disney; two of the largest OTT providers now under licenseReduced debt by $60 million and repurchased $20 million of common stock in 2025
By Adeia Inc. · Via GlobeNewswire · February 23, 2026
Remitly Announces Upcoming Webinar and Investor Conference Participation
SEATTLE, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ: RELY) (“Remitly”), a trusted provider of financial services that transcend borders, today announced that its management team will present at the following investor conferences:
By Remitly, Inc. · Via GlobeNewswire · February 23, 2026
Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution
Highlights
By Myriad Genetics, Inc. · Via GlobeNewswire · February 23, 2026
ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Updates
Reported rinzimetostat (formerly ORIC-944) Phase 1b data that continue to demonstrate potential best-in-class efficacy and safety in mCRPC; selected provisional RP2Ds and initiated dose optimization in combination with AR inhibitors
By ORIC Pharmaceuticals · Via GlobeNewswire · February 23, 2026
Robinhood Markets, Inc. to Present at the Citizens Technology Conference on March 2, 2026
MENLO PARK, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today announced that it will be participating in the upcoming Citizens Technology Conference on Monday, March 2, 2026.
By Robinhood Markets, Inc. · Via GlobeNewswire · February 23, 2026
Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference
EMERYVILLE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Metagenomi Therapeutics, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients, today announced that Jian Irish, Ph.D., M.B.A., President and Chief Executive Officer of the Company, will participate in a fireside chat at the 46th Annual TD Cowen Healthcare Conference, being held in Boston, MA, on Monday, March 2, 2026 at 11:10 a.m. ET.
By Metagenomi, Inc. · Via GlobeNewswire · February 23, 2026
MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026
ROCKVILLE, Md., Feb. 23, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that it will release financial results for the fourth quarter and full year 2025 after the U.S. market close on Tuesday, March 24th, 2026. Company management will host a conference call to discuss financial results at 4:30 p.m. Eastern Time.
By MaxCyte, Inc · Via GlobeNewswire · February 23, 2026
PROCEPT BioRobotics® Announces Updated Dates for 4Q25 Earnings Conference Call and Investor Day
SAN JOSE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that it has updated the timing of its previously announced fourth quarter 2025 earnings conference call and Investor Day due to significant travel disruptions caused by inclement weather.
By PROCEPT BioRobotics · Via GlobeNewswire · February 23, 2026
Galapagos Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
Mechelen, Belgium; February 23, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) today reported its financial results for the full year 2025 and provided an update on the fourth quarter 2025 and its year-to-date performance.
By Galapagos NV · Via GlobeNewswire · February 23, 2026
Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board
WATERTOWN, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced it has appointed François Nader, M.D., MBA, as an independent director to its Board of Directors, effective April 1, 2026, at which time he will also assume the role of Chair of the Board.
By Tectonic Therapeutic · Via GlobeNewswire · February 23, 2026
Skyward Specialty Insurance Group Reports Fourth Quarter 2025 Results
HOUSTON, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Skyward Specialty Insurance Group, Inc. (Nasdaq: SKWD) (“Skyward Group” or the “Company”), today reported fourth quarter 2025 net income of $43.2 million, or $1.03 per diluted share, compared to $14.4 million, or $0.35 per diluted share, for the same 2024 period. Net income for the year ended 2025 was $170.0 million, or $4.07 per diluted share, compared to $118.8 million, or $2.87 per diluted share, for the same 2024 period.
Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference
CARLSBAD, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at the 2026 Canaccord Genuity Musculoskeletal Conference on March 2, 2026 at 11:30 AM CST in New Orleans, LA.  
By Carlsmed · Via GlobeNewswire · February 23, 2026
Kratos Reports Fourth Quarter and Full Year 2025 Financial Results
Fourth Quarter 2025 Revenues of $345.1 Million Reflect 21.9 Percent Growth and 20.0 Percent Organic Growth Over Fourth Quarter 2024 Revenues of $283.1 Million
Beam Therapeutics to Host Investor Webcast for Fourth Quarter and Year-End 2025 Financial Results and New Liver-targeted Genetic Disease Program
CAMBRIDGE, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will announce its fourth quarter and full year 2025 financial results and a new liver-targeted genetic disease program on an investor webcast on Tuesday, February 24, 2026, at 8:00 a.m. ET.The live webcast will be available in the investor section of the company's website at www.beamtx.com and will be archived for 60 days following the presentation.
By Beam Therapeutics · Via GlobeNewswire · February 23, 2026
New Frontier Minerals to Present at Australia Investor Day February 26th
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · February 23, 2026
Resolution Minerals Ltd to Present at Australia Investor Day February 26th
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · February 23, 2026
Broad Arrow Presents Lamborghini Miura SV That Spent 52 Years in Single Ownership at its 2026 Amelia Concours Auction
Broad Arrow set to offer incredibly original, matching-numbers, fully evolved 1972 Lamborghini Miura P400 SV at company’s fourth annual Amelia Concours Auction | Set for March 6-7 at the Ritz-Carlton, Amelia Island, the two-day sale is the official auction of the renowned Amelia Concours | Supercars then and now: Remarkable example of the original supercar is offered alongside desirable modern supercars and hypercars including a 2008 Bugatti Veyron EB 16.4 Coupe, a 1988 Porsche 959 SC Reimagined by Canepa, a 2021 McLaren Elva, a 2019 Ford GT Carbon Series, and more | Learn more about all cars on offer and register to bid at broadarrowauctions.com
By Broad Arrow Auctions · Via GlobeNewswire · February 23, 2026
First Hawaiian, Inc. Announces Retirement of Vice Chairman and Leadership Transition in Wealth Management
HONOLULU , Feb. 23, 2026 (GLOBE NEWSWIRE) -- First Hawaiian, Inc. (NASDAQ: FHB) (“First Hawaiian” or the “Company”) announced today that Alan Arizumi, vice chairman of First Hawaiian, Inc. and First Hawaiian Bank, will retire effective April 3, 2026, following more than 40 years of service.
By First Hawaiian, Inc. · Via GlobeNewswire · February 23, 2026
YourUpdateTV speaks with Airbnb: How Local Residents Can Earn from the World Cup Travel Surge
Airbnb is offering $750 USD to new FIFA World Cup 2026™ hosts
By D S Simon · Via GlobeNewswire · February 23, 2026
Current Report on Operational Status at Certain Mexican Airports
MEXICO CITY, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Grupo Aeroméxico, S.A.B. de C.V. (“Aeroméxico”) (NYSE: AERO & BMV: AERO) informs the market that, following recent events that affected airport operations in Guadalajara (GDL), Puerto Vallarta (PVR), Tepic (TPQ) and Manzanillo (ZLO), the Company is in the process of restoring its operations in these stations.
By Grupo Aeroméxico, S.A.B. de C.V. · Via GlobeNewswire · February 23, 2026
Blank Rome Expands in Pittsburgh with Addition of Leading Corporate and M&A Partners Bob Zinn and Megan Wotherspoon
Pittsburgh, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Blank Rome LLP is pleased to announce that Robert P. “Bob” Zinn and Megan A. Wotherspoon have joined the firm’s Pittsburgh office as partners in the Corporate, M&A, and Securities group and the Financial Services industry team. They join Blank Rome from K&L Gates, where Bob co-led its firm-wide corporate practice from 2007 to 2023 and was a founder of its manufacturing and FinTech industry groups.
By Blank Rome LLP · Via GlobeNewswire · February 23, 2026
Berkadia Partners With 235 Unique Capital Sources in 2025, Up 19% Year-Over-Year
Berkadia’s loan production volume tops $35B in 2025.
By Berkadia · Via GlobeNewswire · February 23, 2026
Greif, Inc. Declares Quarterly Dividend
DELAWARE, Ohio, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Greif, Inc. (NYSE: GEF, GEF.B), a global leader in industrial packaging products and services, announced today that its Board of Directors has declared quarterly cash dividends of $0.56 per share on its Class A Common Stock, and $0.84 per share on its Class B Common Stock.
By Greif, Inc. · Via GlobeNewswire · February 23, 2026
Puerto Rico Real Estate Summit Returns in 2026 to Bring Together the Island’s Leading Real Estate Development and Investment Leaders
Government, banking, developers, investors, and experts in infrastructure, housing, and data will examine Puerto Rico’s economic future and development
By RED Atlas · Via GlobeNewswire · February 23, 2026
NeighborWorks® America Convenes National Leaders in Chicago to Advance Affordable Housing and Community Development
CHICAGO, Feb. 23, 2026 (GLOBE NEWSWIRE) -- In a city defined by strong neighborhoods and enduring civic leadership, NeighborWorks® America will convene well over 1,000 housing and community development professionals Feb. 23-27 for the 2026 NeighborWorks Training Institute.
By NeighborWorks America · Via GlobeNewswire · February 23, 2026
CORCEPT THERAPEUTICS INCORPORATED (CORT) INVESTOR ALERT Investors With Large Losses in Corcept Therapeutics Incorporated Should Contact Bernstein Liebhard LLP To Discuss Their Rights
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ: CORT) between October 31, 2024 and December 30, 2025, inclusive.
By Bernstein Liebhard LLP · Via GlobeNewswire · February 23, 2026
ZYNEX, INC. (ZYXIQ) INVESTOR ALERT Investors With Large Losses in Zynex, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Zynex, Inc. (“Zynex” or the “Company”) (OTC: ZYXIQ) between February 25, 2021 and December 15, 2025, inclusive.
By Bernstein Liebhard LLP · Via GlobeNewswire · February 23, 2026
Dunham House Hosts Appreciation Lunch for Lund Ross Sub Contractor’s Construction Crews
Honoring the Skilled Trades Building a Place of Service and Remembrance
STACK Infrastructure Announces Data Center Developments Supporting Economic Growth in Louisiana
Multi-campus development grounded in responsible development principles, long-term infrastructure investment, and sustained economic impact across northwest Louisiana
By STACK Infrastructure, Inc. · Via GlobeNewswire · February 23, 2026
SupplySide Fresh 2026: Expanded Expert Insights to Transform Health and Nutrition Industry Onboarding
Online education and networking tailored to support businesses seeking an effective industry onboarding solution and professionals looking to fast-track career growth
By SupplySide · Via GlobeNewswire · February 23, 2026
Picogrid and Guardian RF Partner to Deliver Drone Defense for Space Launch Operations at Vandenberg Space Force Base
By Picogrid · Via GlobeNewswire · February 23, 2026
U.S. Crypto Derivatives Traders Checked Risk 2× More Often in 2025, Analysis of 880,000 Setups Shows
CÓRDOBA, Spain, Feb. 23, 2026 (GLOBE NEWSWIRE) -- U.S.-based retail crypto derivatives traders checked liquidation risk roughly twice as often as the global average in 2025, according to data from Leverage.Trading, which analyzed roughly 880,000 anonymized pre-trade setups. The pattern indicates traders increasingly shifted into defense mode well ahead of major liquidation events, suggesting early signs of market stress may emerge before forced exits.
By Leverage.Trading · Via GlobeNewswire · February 23, 2026
AI/R’s Intelligent AI Agent for Recruitment Operations Now Available in the Microsoft Marketplace
Microsoft customers worldwide can now discover and deploy Llia through Microsoft Marketplace, accessing trusted solutions that accelerate innovation and business transformation with unified integration across Microsoft products
By AI/R Group US Holding Corp · Via GlobeNewswire · February 23, 2026
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · February 23, 2026
ZYXIQ DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Zynex To Contact Him Directly To Discuss Their Options
By Faruqi & Faruqi LLP · Via GlobeNewswire · February 23, 2026
ROSEN, LEADING INVESTOR COUNSEL, Encourages Plug Power Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PLUG
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · February 23, 2026